D.E. Shaw & Co’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,217
Closed -$595K 4202
2019
Q4
$595K Buy
2,217
+1,319
+147% +$332K ﹤0.01% 3303
2019
Q3
$273K Sell
898
-2,228
-71% -$685K ﹤0.01% 3507
2019
Q2
$1.03M Buy
3,126
+197
+7% +$100K ﹤0.01% 2661
2019
Q1
$1.83M Buy
2,929
+1,715
+141% +$782K ﹤0.01% 2207
2018
Q4
$302K Buy
1,214
+936
+337% +$372K ﹤0.01% 3342
2018
Q3
$129K Sell
278
-12
-4% -$5.81K ﹤0.01% 3599
2018
Q2
$157K Sell
290
-383
-57% -$230K ﹤0.01% 3584
2018
Q1
$385K Sell
673
-953
-59% -$602K ﹤0.01% 3021
2017
Q4
$1.04M Sell
1,626
-717
-31% -$505K ﹤0.01% 2556
2017
Q3
$2.21M Buy
2,343
+305
+15% +$233K ﹤0.01% 1950
2017
Q2
$1.78M Sell
2,038
-182
-8% -$149K ﹤0.01% 2044
2017
Q1
$1.53M Buy
2,220
+712
+47% +$469K ﹤0.01% 2023
2016
Q4
$1.09M Sell
1,508
-1,084
-42% -$749K ﹤0.01% 2405
2016
Q3
$1.91M Buy
2,592
+1,434
+124% +$1.16M ﹤0.01% 1968
2016
Q2
$965K Buy
1,158
+1,002
+642% +$932K ﹤0.01% 2431
2016
Q1
$128K Buy
+156
New +$123K ﹤0.01% 3256
2015
Q1
Sell
-773
Closed -$874K 3942
2014
Q4
$874K Buy
+773
New +$793K ﹤0.01% 2926
2014
Q2
Sell
-91
Closed -$127K 4479
2014
Q1
$127K Sell
91
-428
-82% -$557K ﹤0.01% 4150
2013
Q4
$596K Buy
+519
New +$716K ﹤0.01% 3602

Other funds holding RMTI

D.E. Shaw & Co's RMTI Position: Q1 2020 in Review

D.E. Shaw & Co sold out of Rockwell Medical (RMTI) in Q1 2020, closing a stake of 2,217 shares — an estimated $595K sold.

D.E. Shaw & Co first reported a position in RMTI in Q4 2013 and held it in 19 quarters. The position peaked at $2.21M in Q3 2017. 79 funds tracked by Wall St. Rank hold RMTI as of Q1 2020.

  • D.E. Shaw & Co reported no remaining Rockwell Medical position as of Q1 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 2,217 Rockwell Medical shares in Q1 2020, an estimated $595K.
  • D.E. Shaw & Co first reported a position in Rockwell Medical in Q4 2013 and held it in 19 quarters.
  • D.E. Shaw & Co's Rockwell Medical position peaked at $2.21M in Q3 2017.
  • 79 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.